This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Innovations of Jonathan D. Scudder
Introduction
Jonathan D. Scudder is a notable inventor based in San Antonio, Texas. He has made significant contributions to the field of pyrogenicity testing, particularly in the development of methods and assays that enhance the sensitivity and speed of endotoxin detection in pharmaceuticals and medical devices. With two patents to his name, his work is crucial for ensuring the safety of products that come into contact with blood or cerebrospinal fluid.
Latest Patents
Scudder's latest patents include the "Endotoxin testing assay and method of same" and the "Limulus amoebocyte lysate assay and method of same." Both patents focus on a pyrogenicity test method that utilizes a Limulus Amoebocyte Lysate (LAL) assay monitored with a photonic-crystal biosensor. This innovative approach allows for rapid and ultrahigh sensitivity testing by detecting shifts in the resonant condition of an open microcavity, which is affected by changes in the refractive index of the analyte solutions used. These advancements are vital for the safety and efficacy of parenteral pharmaceuticals and medical devices.
Career Highlights
Jonathan D. Scudder is affiliated with the University of Texas System, where he continues to contribute to research and development in his field. His work has garnered attention for its potential to revolutionize endotoxin testing, making it faster and more reliable.
Collaborations
One of his notable collaborators is Jing Yong Ye, with whom he has worked on various projects related to endotoxin testing and biosensor technology.
Conclusion
Jonathan D. Scudder's innovations in endotoxin testing represent a significant advancement in medical safety. His contributions are essential for the development of reliable testing methods that protect patients and ensure the quality of medical products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
